SCHEMBL10377556

SCHEMBL10377556

Cc1ccc(C(=O)c2ccc(=O)[nH]c2C)cc1

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.52
▸ LMNA P02545 2/20 0.52
▸ AKR1C3 P42330 1/20 0.47
▸ SRD5A2 P31213 2/20 0.46
▸ MAPT P10636 2/20 0.42
▸ GAA P10253 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ CES2 O00748 1/20 0.42
▸ CES1 P23141 1/20 0.42
▸ RAB9A P51151 2/20 0.41
▸ HPGD P15428 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ NPC1 O15118 1/20 0.40
▸ COMT P21964 1/20 0.40
▸ NR4A1 P22736 1/20 0.39
▸ KDM5A P29375 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10378565 0.88 MAPT (0.47) ALDH1A1LMNASRD5A2MAPTGAA
SCHEMBL10378678 0.86 GRM5 (0.43) ALDH1A1LMNAMAPTCES2CES1
SCHEMBL10377589 0.86 MAPT (0.46) LMNAAKR1C3MAPTCES2CES1
SCHEMBL10378571 0.86 NR4A1 (0.45) SRD5A2MAPTGAACES2CES1
SCHEMBL10378560 0.86 MAPT (0.47) ALDH1A1LMNAAKR1C3MAPTGAA
SCHEMBL10377417 0.83 NPC1 (0.54) ALDH1A1LMNAMAPTGAACES2
SCHEMBL10377414 0.83 PLK1 (0.45) ALDH1A1LMNASRD5A2MAPTL3MBTL1
SCHEMBL10377855 0.82 CA1 (0.42) ALDH1A1MAPT
SCHEMBL10378895 0.81 MAPT (0.50) ALDH1A1LMNASRD5A2MAPTGAA
SCHEMBL10676916 0.80 ALDH1A1 (0.46) ALDH1A1LMNAAKR1C3SRD5A2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0168037-B1 1-6-NAPHTHYRIDIN-2(1H)-ONES USEFUL AS CARDIOTONICS STERLING DRUG INC. (US) 1990-02-07 — — EP disclosed
EP-0168037-A2 1-6-Naphthyridin-2(1H)-ones useful as cardiotonics STERLING DRUG INC. (US) 1986-01-15 — — EP disclosed
US-4560691-A 5-(Phenyl)-1,6-naphthyridin-2(1H)-ones, their cardiotonic use and preparation STERLING DRUG INC. (US) 1985-12-24 — — US disclosed
Send feedback